Explore the full directors' dealings record of 비씨월드제약, a publicly traded company based in South Korea. Shares are listed on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 비씨월드제약 has published 5 reports. Market capitalisation: €56.3bn. The latest transaction was disclosed on 14 April 2026 (Purchase). Among the most active insiders: 홍성한. All data is openly available.
5
Insider Decl.
0
Thresholds
€875,106
5 ops.
Buy Volume
·
0 ops.
Sell Volume
30Σ signal
Buys €875,106· Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.